Candel Therapeutics regains Nasdaq minimum bid price compliance

Candel Therapeutics, Inc.

Received Nasdaq notice on Dec 28, 2023 that bid price compliance is regained.
Previously warned on Nov 15, 2023 for closing below $1.00 for 30 consecutive days.
Nasdaq has closed the matter; no further action required.
Company's common stock (CADL) continues trading on Nasdaq Global Market.

item 8.01

Candel Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-000539

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.